In COPD, a high MALAT1 expression mediated by a hypomethylated promoter elevates cyclooxygenase 2 (COX2) expression via inhibiting miR-146a, which can affect the pulmonary functions in COPD patients [79]. Here, MALAT1 is linked to chronic obstructive pulmonary disease.